Discover Lecheng’s five premium non-surgical anti-aging and skincare programs – exosome therapy, vascular rejuvenation, PiQo4 laser, DFPP blood purification, and RF tightening – offering visible, safe, and swift results. Learn more and book your consultation.
Autologous NK cell therapy for solid tumors in Lecheng: efficacy, limitations, costs, and patient selection.
Discover the approved MSC therapy for refractory type 2 diabetes at Lecheng Ciming. Evidence-based outcomes, weight-based pricing, and a complete patient guide.
Discover VUM02 stem cell therapy for decompensated cirrhosis at Lecheng Maisel. Evidence‑based, off‑the‑shelf, and now available. Learn costs, mechanisms, and who qualifies.
Cyclogest® progesterone pessary is now available at Lecheng for IVF luteal support. Vaginal or rectal use offers a gentler alternative to injections and gels. Learn more.
China’s first Vutrisiran treatment for ATTR-CM performed at Lecheng’s Ruijin Hainan Hospital. This siRNA therapy targets the root cause, reducing mortality and cardiovascular events with quarterly injections.
Lecheng introduces Artegraft® biologic vascular graft in China's first pancreatic cancer surgery with celiac artery reconstruction – offering new hope for patients with vascular involvement. Learn more about this breakthrough.
Boao Lecheng is a special medical zone in Hainan, China, granting fast-track access to global FDA/EMA-approved drugs and advanced treatments locally.
CHOLBAM® (cholic acid capsules) for inborn errors of bile acid synthesis is now accessible in Lecheng, included in the 2026 Global Special Drug Insurance – offering rare disease patients a targeted therapy closer to home.
Discover 5 innovative joint regeneration therapies at Lecheng for osteoarthritis and cartilage repair – Supintro, Hyalofast, RegenoGel, PRP+HA, and nSTRIDE – offering non-surgical solutions with lasting results.
Explore four revolutionary hair restoration treatments at Lecheng – Medicap artificial hair, Hairstetics implants, CARETOPIC spray, and Regena cellular therapy – offering safe, effective alternatives to conventional hair loss solutions.
Lecanemab subcutaneous auto-injector – the world's first at-home anti-Aβ Alzheimer's drug – is now available at Ruijin Hainan Hospital in Lecheng. Approved for early-stage Alzheimer's, it enables weekly self-administration in 15 seconds, reducing hospital visits and improving adherence.
Your trusted local gateway to Boao Lecheng International Medical Tourism Pilot Zone. We bridge the gap between global patients and world-class innovative healthcare.
© Copyright 2025 - 2026 LechengMedical.com, All Rights Reserved. | Privacy Policy | Terms of Service | Medical Disclaimer
